RESEARCH

27. Marrie TJ. burnetii pneumonia. Eur Respir J. 2003;21:713–9. 35. Talan DA, Stamm WE, Hooton TM, Moran DJ, Burke T, Travani DOI: 10.1183/09031936.03.00095403 A, et al. Comparison of ciprofl oxacin (7 days) and trimethoprim- 28. Ayres JG, Flint N, Smith EG, et al. Post-infection fatigue syn- sulfamethoxazole (14 days) for acute uncomplicated pyelonephri- drome following . QJM. 1998;91:105–23. DOI: 10.1093/ tis in women: a randomized trial. JAMA. 2000;283:1583–90. DOI: qjmed/91.2.105 10.1001/jama.283.12.1583 29. Marmion BP, Shannon M, Maddocks I, Storm P, Penttila I. Protract- 36. Kocak Z, Hatipoglu CA, Ertem G, Kinikli S, Tufan A, Irmak H, ed debility and fatigue after acute Q fever. Lancet. 1996;347:977–8. et al. Trimethoprim-sulfamethoxazole induced rash and fatal he- DOI: 10.1016/S0140-6736(96)91469-5 matologic disorders. J Infect. 2006;52:e49–52. DOI: 10.1016/j. 30. Smith DL, Ayres JG, Blair I, Burge PS, Carpenter MJ, Caul EO, et al. jinf.2005.05.008 A large Q fever outbreak in the West Midlands: clinical aspects. Re- 37. See S, Mumford JM. Trimethoprim/sulfamethoxazole-induced toxic spir Med. 1993;87:509–16. DOI: 10.1016/0954-6111(93)90006-L epidermal necrolysis. Ann Pharmacother. 2001;35:694–7. DOI: 31. Raoult D, Levy PY, Dupont HT, Chicheportiche C, Tamalet C, Gas- 10.1345/aph.10310 taut JA, et al. Q fever and HIV infection. AIDS. 1993;7:81–6. DOI: 38. Fennelly KP, Davidow AL, Miller SL, Connell N, Ellner JJ. Air- 10.1097/00002030-199301000-00012 borne infection with Bacillus anthracis—from mills to mail. Emerg 32. Siegman-Igra Y, Kaufman O, Keysary A, Rzotkiewicz S, Shalit I. Q Infect Dis. 2004;10:996–1001. fever endocarditis in Israel and a worldwide review. Scand J Infect Dis. 1997;29:41–9. Address for correspondence: Claire E. Moodie, 754 Centre St #11, Jamaica 33. Fowler RA, Sanders GD, Bravata DM, Nouri B, Gastwirth JM, Pe- Plain, MA 02130, USA; email: [email protected] terson D, et al. Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against an- thrax. Ann Intern Med. 2005;142:601–10. 34. Sabbaj J, Hoagland VL, Shih WJ. Multiclinic comparative study of The opinions expressed by authors contributing to this journal do norfl oxacin and trimethoprim-sulfamethoxazole for treatment of uri- not necessarily refl ect the opinions of the Centers for Disease Con- nary tract infections. Antimicrob Agents Chemother. 1985;27:297– trol and Prevention or the institutions with which the authors are 301. affi liated.

eetymologiatymologia Coxiella [kok′′ se-el′ ə] burnetii Etiologic agent of Q fever, named after American bacteriologist Herald Rea Cox and Australian physician Frank MacFarlane Burnet, who both independently isolated the bacterium in the 1930s. C. burnetii belongs in the family Coxiellaceae, which consists of gram-negative rods without fl agella or a capsule. The occur in ticks and various vertebrates, including humans. Source: Dorland’s illustrated medical dictionary, 31st edition. Philadelphia: Saunders; 2007; American Veterinary Medical Association. Q fever backgrounder. Available from http://www.avma.org/public_health/biosecurity/qfever_bgnd.asp

Now that you’ve read the article, you can listen to the commentary.

Prophylaxis after Exposure to

1566 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 10, October 2008